BIOMATLANTE (Vigneux de Bretagne), a medical device company specialized in bone regeneration, today announced the CE regulatory approval of EZ CURE™ Strip and EZ CURE Plug, a combination of highly purified collagen Type I with its MBCP™ core technology, to extend its range of synthetic bone graft substitutes. BIOMATLANTE will showcase those products at the Eurospine Conference, held 2-4 September 2015 in Copenhagen, Denmark and at the European Association for Osseointegration (EAO) meeting, held 24-26 September 2015 in Stockholm, Sweden.
Main features include:
- A versatile mineralized sponge which absorbs and retains biological fluids.
- High permeability stemming from its unparalleled porosity
- Homogeneous mixture of MBCP™ and highly purified Type I Collagen
The EZ Cure™ Strip and Plug complete the EZ CURE™ line of Collagen products marketed by BIOMATLANTE.
About BIOMATLANTE, experts in bone regeneration
Based near Nantes, France, Biomatlante specializes in synthetic biomaterials for bone regeneration and is a world leader in bone graft technologies, selling its products in over 50 countries. Biomatlante’s products are routinely used in orthopedics and trauma surgery, in spine and dental surgery. BIOMATLANTE strives to integrate a strategy of strong innovation and product development required to meet and exceed the needs of today’s market. Our R&D collaborates closely with universities and research centers across the world, bringing together competences in innovation, technological transfers of new biomaterials, surgical technologies and providing the intellectual protection required to foster long-term projects.
About MBCP™ Technology, worldwide reference in synthetic bone graft
The unique 3-step manufacturing process developed by BIOMATLANTE confers its core MBCP™ biphasic HA/ ß-TCP technology unique properties for hard tissue regeneration. Its micro-macroporous structure mimics that of human bone and provides an ideal osteogenic matrix for bone regeneration in general and tissue engineering in particular.